EMA Explains How To Make Risk Minimization Measures Robust & Effective
Executive Summary
Pharmacovigilance experts speaking at an event organized by the European Medicines Agency discussed the rationale behind revised requirements relating to how drug sponsors must develop and evaluate risk minimization measures and thereby improve the safety of their medicines.